Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
Maternal buprenorphine treatment and fetal neurobehavioral development
Lauren M. Jansson
, Martha Velez
, Krystle McConnell
, Nancy Spencer
, Michelle Tuten
, Hendree E. Jones
,
Van L. King
, Neeraj Gandotra
, Lorraine A. Milio
, Kristin Voegtline
, Janet A. DiPietro
Research output
:
Contribution to journal
›
Article
›
peer-review
33
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Maternal buprenorphine treatment and fetal neurobehavioral development'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Pregnancy
100%
Buprenorphine
100%
Fetal Heart Rate
37%
Smoking
25%
Motor Activity
25%
Development
25%
Therapeutic Procedure
25%
Opioid Abuse
25%
Substance Use Disorder
12%
Drug Megadose
12%
Depression
12%
Drug Therapy
12%
Combination Therapy
12%
Opiate
12%
Methadone
12%
Fetus Monitoring
12%
Fetus
12%
Movement (Physiology)
12%
Recognition
12%
Indicator
12%
Nursing and Health Professions
Buprenorphine
100%
Heart Rate
50%
Woman
50%
Fetus Heart Rate
37%
Infant
25%
Opiate
12%
Combination Therapy
12%
Drug Megadose
12%
Drug Therapy
12%
Depression
12%
Methadone
12%
Pregnancy Outcome
12%
Data Analysis
12%
Heart Rate Variability
12%
Parameters
12%
Indicator
12%
Dose
12%
Acceleration
12%
Pharmacology, Toxicology and Pharmaceutical Science
Buprenorphine
100%
Study Design
25%
Drug Dependence
12%
Depression
12%
Opiate
12%
Indicator
12%
Methadone
12%